C4 Therapeutics (CCCC) Tax Provisions (2019 - 2024)
C4 Therapeutics (CCCC) recorded quarterly Tax Provisions of $131000.0 in Q4 2024, down 53.21% quarter-over-quarter from $280000.0 in Q4 2023, and down 53.21% on a YoY basis from $280000.0 in Q1 2024.
C4 Therapeutics (CCCC) Tax Provisions (2019 - 2024) Analysis & Trends
C4 Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $131000.0 for Q4 2024.
- In Q4 2024, Tax Provisions fell 53.21% year-over-year to $131000.0; the TTM figure through Dec 2024 stood at $131000.0 (down 89.79% YoY), while the FY2025 annual figure was $121000.0, down 7.63% from the prior year.
- Tax Provisions was $131000.0 for Q4 2024 at C4 Therapeutics, down from $280000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.0 million in Q3 2023 to a low of -$168000.0 in Q2 2020.
- Historically, Tax Provisions has averaged $112571.4 across 3 years, with a median of -$124000.0 in 2020.
- Biggest YoY gain for Tax Provisions was 29.17% in 2020; the steepest drop was 125.69% in 2020.
- A 3-year view of Tax Provisions shows it stood at -$124000.0 in 2020, then surged by 325.81% to $280000.0 in 2023, then plunged by 53.21% to $131000.0 in 2024.
- The last three Tax Provisions figures came in at $131000.0 (Q4 2024), $280000.0 (Q4 2023), and $1.0 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | C4 Therapeutics | 520.69 Mn | 285.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 131,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Dec 31, 2020 | -124,000.00 |
| Sep 30, 2020 | -167,000.00 |
| Jun 30, 2020 | -168,000.00 |
| Mar 31, 2020 | -167,000.00 |
| Dec 31, 2019 | -96,000.00 |
| Sep 30, 2019 | 650,000.00 |